Lundbeck
HLUN-B.CO
HK$33.71
Share price
-0.83%
Change (1 day)
-8.43%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
Market capitalization of Lundbeck (HLUN-B.CO)
Market cap: HK$32.38 Billion
As of April 2025 Lundbeck has a market cap of HK$32.38 Billion. This makes Lundbeck the world's 2892th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Lundbeck from 2005 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | HK$32.38 B | -25.14% |
| 2024 | HK$43.26 B | 17.78% |
| 2023 | HK$36.73 B | 30.1% |
| 2022 | HK$28.23 B | 427.27% |
| 2021 | HK$5.35 B | -25.05% |
| 2020 | HK$7.14 B | -9.56% |
| 2019 | HK$7.90 B | -13.31% |
| 2018 | HK$9.11 B | -13.66% |
| 2017 | HK$10.55 B | 25.49% |
| 2016 | HK$8.41 B | 19% |
| 2015 | HK$7.06 B | 72.3% |
| 2014 | HK$4.10 B | -20.69% |
| 2013 | HK$5.17 B | 72.7% |
| 2012 | HK$2.99 B | -41.61% |
| 2011 | HK$5.12 B | 32.62% |
| 2010 | HK$3.86 B | 1.57% |
| 2009 | HK$3.80 B | -18.13% |
| 2008 | HK$4.65 B | -18.52% |
| 2007 | HK$5.70 B | -5.09% |
| 2006 | HK$6.01 B | 25.34% |
| 2005 | HK$4.79 B |